Acera Surgical, Inc. v. Nanofiber Solutions, LLC

CourtDistrict Court, D. Delaware
DecidedOctober 12, 2022
Docket1:20-cv-00980
StatusUnknown

This text of Acera Surgical, Inc. v. Nanofiber Solutions, LLC (Acera Surgical, Inc. v. Nanofiber Solutions, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Acera Surgical, Inc. v. Nanofiber Solutions, LLC, (D. Del. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

ACERA SURGICAL, INC., RETECTIX, LLC, and WASHINGTON UNIVERSITY,

Plaintiffs, C.A. No. 20-980-CFC-JLH v.

NANOFIBER SOLUTIONS, LLC, PARAGEN TECHNOLOGIES LLC, ATREON ORTHOPEDICS LLC, and RENOVODERM LLC,

Defendants,

and

NANOFIBER SOLUTIONS, LLC, and THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK,

Counterclaim Plaintiffs,

v.

ACERA SURGICAL, INC.,

Counterclaim Defendant.

REPORT AND RECOMMENDATION

Pending before the Court are the parties’ claim construction disputes. There are seven patents at issue in this case. Plaintiffs Acera Surgical, Inc., Retectix, LLC, and Washington University (collectively, “Plaintiffs”) are asserting four patents against Defendants Nanofiber Solutions, LLC (“Nanofiber”), Paragen Technologies LLC, Atreon Orthopedics LLC, and Renovoderm LLC. Defendant Nanofiber, as well as The Research Foundation for the State University of New York (collectively, with the other defendants, “Defendants”1), are asserting three patents against Plaintiff Acera Surgical, Inc. All seven patents generally relate to biomedical patches and grafts made from electrospun nanofibers. The parties’ joint claim construction brief indicated that the parties had agreed upon two constructions and had disputes over seven terms spanning five of the patents-in-suit. (D.I. 120.) I held a Markman hearing on August 12, 2022. (“Tr. __.”) Following a lengthy interchange, I instructed the parties to further meet and confer regarding three of the disputed terms. The parties subsequently submitted a joint letter in which they agreed on one term and modified their proposals regarding the other two. (D.I. 136.) Six terms remain in dispute.

I recommend that the parties’ agreed-upon constructions be adopted as follows: Term Recommended Construction

multi-laminar “multiple layers”

ʼ512 patent, claims 1-3, 5-10, 12-14

projection/projections “a protrusion or bulge”

ʼ228 patent, claims 7, 8, 14, 19

indentation/indentations “a recess or depression”

ʼ228 patent, claims 7, 8, 10, 14, 16, 19

1 The parties’ briefing refers to any party who isn’t a Plaintiff as a “Defendant.” (D.I. 120.) This Report and Recommendation will do the same. 2 Further, for the reasons discussed in more detail below, I recommend that the disputed terms be construed as follows: Term Recommended Construction

first layer/second layer “first distinct and separately deposited thickness of material” ʼ512 patent, claims 1, 8, 15 “second distinct and separately deposited thickness of material”

first layer/second layer/third layer “first distinct and separately deposited thickness of material” ʼ687 patent, claims 1, 5, 7 “second distinct and separately deposited thickness of material” “third distinct and separately deposited thickness of material”

first plurality/second plurality “first distinct and separately deposited grouping” ʼ444 patent, claims 1-8, 10, 16, 17 “second distinct and separately deposited grouping”

prepared from at least one solution of at least Process limitation of a product-by-process one polymer utilizing a process selected from claim the group consisting of electro-spinning, electro-blowing, blowing-assisted electro- spinning, and solution blowing

ʼ166 patent, claim 26

prepared from about 1 to about 5 solutions of Process limitation of a product-by-process from about 1 to about 5 polymers claim

ʼ166 patent, claim 27

3 formed by electrospinning fibers Process limitation of a product-by-process claim ʼ765 patent, claims 1, 49

I. LEGAL STANDARDS The purpose of the claim construction process is to “determin[e] the meaning and scope of the patent claims asserted to be infringed.” Markman v. Westview Instruments, Inc., 52 F.3d 967, 976 (Fed. Cir. 1995) (en banc), aff’d, 517 U.S. 370 (1996). When the parties have an actual dispute regarding the proper scope of claim terms, their dispute must be resolved by the judge, not the jury. Id. at 979. The Court only needs to construe a claim term if there is a dispute over its meaning, and it only needs to be construed to the extent necessary to resolve the dispute. Vivid Techs., Inc. v. Am. Sci. & Eng’g, Inc., 200 F.3d 795, 803 (Fed. Cir. 1999). “[T]here is no magic formula or catechism for conducting claim construction.” Phillips v. AWH Corp., 415 F.3d 1303, 1324 (Fed. Cir. 2005). But there are guiding principles. Id. “The inquiry into how a person of ordinary skill in the art understands a claim term provides an objective baseline from which to begin claim interpretation.” Id. at 1313. In some cases, the ordinary meaning of a claim term, as understood by a person of ordinary skill in the art, is readily apparent even to a lay person and requires “little more than the application of the widely accepted meaning of commonly understood words.” Id. at 1314. Where the meaning is not readily apparent, however, the court may look to “those sources available to the public that show what a person of skill in the art would have understood disputed claim language to mean.” Innova/Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111, 1116 (Fed. Cir. 2004). Those sources include “the words of the claims themselves, the remainder of the specification, the prosecution history, 4 and extrinsic evidence concerning relevant scientific principles, the meaning of technical terms, and the state of the art.” Id. “[T]he claims themselves provide substantial guidance as to the meaning of particular claim terms.” Phillips, 415 F.3d at 1314. For example, “the context in which a term is used in the asserted claim can be highly instructive.” Id. Considering other, unasserted, claims can also be helpful. Id. “For example, the presence of a dependent claim that adds a particular limitation gives rise to a presumption that the limitation in question is not present in the independent claim.” Id. at 1314-15. In addition, the “claims must be read in view of the specification, of which they are a part.”

Id. at 1315 (quoting Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996)). The specification “is always highly relevant to the claim construction analysis.” Id. (quoting Vitronics, 90 F.3d at 1582). The specification may contain a special definition given to a claim term by the patentee, in which case, the patentee’s lexicography governs. Id. at 1316. The specification may also reveal an intentional disclaimer or disavowal of claim scope. Id. However, “even when the specification describes only a single embodiment, the claims of the patent will not be read restrictively unless the patentee has demonstrated a clear intention to limit the claim scope using words or expressions of manifest exclusion or restriction.” Hill-Rom Servs., Inc. v. Stryker Corp., 755 F.3d 1367, 1372 (Fed. Cir. 2014) (internal marks omitted).

Courts should also consider the patent’s prosecution history. Phillips, 415 F.3d at 1317.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bonito Boats, Inc. v. Thunder Craft Boats, Inc.
489 U.S. 141 (Supreme Court, 1989)
Abbott Laboratories v. Sandoz, Inc.
566 F.3d 1282 (Federal Circuit, 2009)
In Re Donald H. Thorpe
777 F.2d 695 (Federal Circuit, 1985)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Biacore, AB v. Thermo Bioanalysis Corp.
79 F. Supp. 2d 422 (D. Delaware, 1999)
Hill-Rom Services, Inc. v. Stryker Corporation
755 F.3d 1367 (Federal Circuit, 2014)
Purdue Pharma L.P. v. Epic Pharma, LLC
811 F.3d 1345 (Federal Circuit, 2016)
Aylus Networks, Inc. v. Apple Inc.
856 F.3d 1353 (Federal Circuit, 2017)
Hazani v. United States International Trade Commission
126 F.3d 1473 (Federal Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
Acera Surgical, Inc. v. Nanofiber Solutions, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/acera-surgical-inc-v-nanofiber-solutions-llc-ded-2022.